[an error occurred while processing this directive]
  3 by 5 Initiative > Media centre
printable version

WHO, UNAIDS and UNICEF modify recommendations for cotrimoxazole prophylaxis in children: Previous page | 1,2,3,4,5,6,7,8,9,10,11

Monitoring and evaluation

  

In order to monitor progress towards the delivery of comprehensive AIDS treatment, care and support, National programmes should assess the extent to which the range of HIV related care services are being implemented and set clear targets for children. Cotrimoxazole prophylaxis is an essential health intervention that needs to be included in child health services (including IMCI), PMTCT services, TB services and HIV ART treatment services (facility based and community based). Monitoring of progress towards achieving this should include:

  • Monitoring the provision of cotrimoxazole prophylaxis to children and adolescents within existing care services (including, paediatric HIV care, home based care and IMCI).
  • Documenting the proportion of HIV-exposed infants in PMTCT programs who receive cotrimoxazole interventions until confirmation of HIV infection status.
  • National monitoring of antimicrobial resistance of pneumonia, dysentery and malaria in children is recommended because cotrimoxazole is widely used for other clinical indications.

WHO, UNAIDS and UNICEF modify recommendations for cotrimoxazole prophylaxis in children: 1,2,3,4,5,6,7,8,9,10,11 | Next page

[an error occurred while processing this directive]